PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1515546
PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1515546
Biotherapeutics Virus removal filters Market size was valued at USD 455.6 Million in 2023, expanding at a CAGR of 8.80% from 2024 to 2032.
The Biotherapeutics Virus Removal Filters are designed to remove viruses from biotherapeutic medication products, such as biopharmaceuticals and plasma derivatives. Biotherapeutic filers are comprised of hydrophilized polyvinylidene fluoride (PVDF). These filters filter high-concentration protein solutions quickly and effectively while also removing viruses.
Biotherapeutics Virus removal filters Market- Market Dynamics
Growing Demand for Biotherapeutics and Biopharmaceutical Products Drives Market Growth
One of the major factors driving the growth in the Biotherapeutics Virus removal filters Market is the increased demand for biopharmaceutical products and therapies. The relatively new occurrences of complex diseases have been witnessing greater adoption of biologics and bio-therapeutics for treatment, resulting in the emerging need to ensure stringent viral safety during their production process. The virus removal filters are very important in biotherapeutic products to ensure that the product is pure and safe through the effective removal of viruses and other contaminants. On account of the global expansion of the biopharmaceutical industry, the demands for advanced virus removal filtration technologies grow in proportion, driving the market growth of the biotherapeutics virus removal filters. This trend underlines the requirement for strong filtration solutions to ensure product quality and adherence to set regulatory requirements in the manufacture of biotherapeutics.
Biotherapeutics Virus Removal Filters Market- Key Insights
As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 8.80% over the forecast period (2024-2032)
Based on Technology segmentation, Size Exclusion Technology is the major market category.
Based on application segmentation, Monoclonal antibodies continue to be the fastest-growing segment in 2023
Based on region, North America was the leading revenue generator in 2023
The Global Biotherapeutics Virus removal filters Market is segmented based on Technology, Application, End-user, and Region.
The market is divided into two categories based on Technology: Size Exclusion Technology and Depth Filtration Technology. Size Exclusion Technology is a dominant market category. The biotherapeutics sector prefers size exclusion technology in virus elimination filters because it purifies particles based on size differentiation. It is an excellent means of virus clearance because it allows diffusible molecules to pass through while separating bigger molecules, including viruses.
The market is divided into four categories based on application: Monoclonal Antibodies, Blood & Plasma, Enzymes and Proteins. Monoclonal antibodies remain to be the fastest-growing sector in the Biotherapeutics Virus Removal Filter Market. Monoclonal antibodies have been increasingly popular in recent years due to their therapeutic usage in a variety of disorders, including cancer, autoimmune, and infectious diseases. With biopharmaceuticals continuing to invest heavily in developing monoclonal antibody-based medicines, there has been an ongoing demand for efficient virus elimination filters to ensure product safety and quality.
Biotherapeutics Virus removal filters Market- Geographical Insights.
Geographically, this market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business. North America was the largest market for biotherapeutics virus removal filters, and this trend is likely to continue into the forecast period due to an increase in research on monoclonal antibodies (mAbs) and recombinant proteins, both of which require virus removal filters. Furthermore, technological advancements in the healthcare sector in the region are likely to boost the biotherapeutics virus elimination filter market.
Europe is predicted to have the second-largest market share in the global biotherapeutics virus removal filters market due to improved medical facilities and the widespread availability of biotherapeutics virus removal filters in the area. Increasing healthcare investments, as well as the existence of important market suppliers and providers, all boost the European market. The worldwide biotherapeutics virus removal filter market is gaining pace in the area as research centers expand and the biopharmaceutical sector grows.
In the Biotherapeutics Virus Removal Filters Market Competitive Landscape, several companies are actively battling to produce sophisticated virus removal filters for biotherapeutic manufacturing processes. Merck Group, Sartorius AG, Asahi Kasei Corporation, and Pall Corporation are among the leading providers of new virus elimination filtration technology. These firms specialize in creating filters that successfully eliminate viruses from biopharmaceutical goods, ensuring their safety and quality. Understanding the competitive landscape in this industry will assist stakeholders in finding reputable partners for implementing virus elimination filters into their biotherapeutic manufacturing processes.
In April 2022, Merck announced an upgrade in its bioprocessing portfolio with the purchase of MAST(R). With the acquisition of the MAST(R) platform, the bioprocessing offering now includes fully automated sampling.
GLOBAL BIOTHERAPEUTICS VIRUS REMOVAL FILTERS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
Pall Corporation
Z-Medica LLC
Asahi Kasei Corporation
Merck KGaA
Sartorius AG
Others